RESUMO
Cholera is a severe acute, highly transmissible diarrheal disease which affects many low- and middle-income countries. Outbreaks of cholera are confirmed using microbiological culture, and additional cases during the outbreak are generally identified based on clinical case definitions, rather than laboratory confirmation. Many low-resource areas where cholera occurs lack the capacity to perform culture in an expeditious manner. A simple, reliable, and low-cost rapid diagnostic test (RDT) would improve identification of cases allowing rapid response to outbreaks. Several commercial RDTs are available for cholera testing with two lines to detect either serotypes O1 and O139; however, issues with sensitivity and specificity have not been optimal with these bivalent tests. Here, we report an evaluation of a new commercially available cholera dipstick test which detects only serotype O1. In both laboratory and field studies in Kenya, we demonstrate high sensitivity (97.5%), specificity (100%), and positive predictive value (100%) of this new RDT targeting only serogroup O1. This is the first field evaluation for the new Crystal VC-O1 RDT; however, with these high-performance metrics, this RDT could significantly improve cholera outbreak detection and improve surveillance for better understanding of cholera disease burden.
Assuntos
Cólera/diagnóstico , Técnicas de Laboratório Clínico/normas , Kit de Reagentes para Diagnóstico/normas , Adolescente , Adulto , Criança , Pré-Escolar , Técnicas de Laboratório Clínico/economia , Técnicas de Laboratório Clínico/instrumentação , Técnicas de Laboratório Clínico/métodos , Diarreia/epidemiologia , Surtos de Doenças , Fezes/microbiologia , Humanos , Lactente , Recém-Nascido , Quênia , Valor Preditivo dos Testes , Sensibilidade e Especificidade , Sorogrupo , Vibrio cholerae O1/classificação , Vibrio cholerae O1/isolamento & purificação , Adulto JovemRESUMO
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID-19), a newly emerging human infectious disease. Because no specific antiviral drugs or vaccines are available to treat COVID-19, early diagnostics, isolation, and prevention are crucial for containing the outbreak. Molecular diagnostics using reverse transcription polymerase chain reaction (RT-PCR) are the current gold standard for detection. However, viral RNAs are much less stable during transport and storage than proteins such as antigens and antibodies. Consequently, false-negative RT-PCR results can occur due to inadequate collection of clinical specimens or poor handling of a specimen during testing. Although antigen immunoassays are stable diagnostics for detection of past infection, infection progress, and transmission dynamics, no matched antibody pair for immunoassay of SARS-CoV-2 antigens has yet been reported. In this study, we designed and developed a novel rapid detection method for SARS-CoV-2 spike 1 (S1) protein using the SARS-CoV-2 receptor ACE2, which can form matched pairs with commercially available antibodies. ACE2 and S1-mAb were paired with each other for capture and detection in a lateral flow immunoassay (LFIA) that did not cross-react with SARS-CoV Spike 1 or MERS-CoV Spike 1 protein. The SARS-CoV-2 S1 (<5 ng of recombinant proteins/reaction) was detected by the ACE2-based LFIA. The limit of detection of our ACE2-LFIA was 1.86 × 105 copies/mL in the clinical specimen of COVID-19 Patients without no cross-reactivity for nasal swabs from healthy subjects. This is the first study to detect SARS-CoV-2 S1 antigen using an LFIA with matched pair consisting of ACE2 and antibody. Our findings will be helpful to detect the S1 antigen of SARS-CoV-2 from COVID-19 patients.
Assuntos
Betacoronavirus/isolamento & purificação , Técnicas Biossensoriais/instrumentação , Técnicas de Laboratório Clínico , Infecções por Coronavirus/diagnóstico , Peptidil Dipeptidase A/química , Pneumonia Viral/diagnóstico , Glicoproteína da Espícula de Coronavírus/análise , Enzima de Conversão de Angiotensina 2 , Anticorpos Monoclonais/química , Técnicas Biossensoriais/economia , COVID-19 , Teste para COVID-19 , Técnicas de Laboratório Clínico/economia , Técnicas de Laboratório Clínico/instrumentação , Infecções por Coronavirus/economia , Desenho de Equipamento , Humanos , Imunoensaio/economia , Imunoensaio/instrumentação , Imunoconjugados/química , Pandemias , SARS-CoV-2 , Sensibilidade e Especificidade , Fatores de TempoRESUMO
Currently the world is being challenged by a public health emergency caused by the coronavirus pandemic (COVID-19). Extensive efforts in testing for coronavirus infection, combined with isolating infected cases and quarantining those in contact, have proven successful in bringing the epidemic under control. Rapid and facile screening of this disease is in high demand. This review summarises recent advances in strategies reported by international researchers and engineers concerning how to tackle COVID-19 via rapid testing, mainly through nucleic acid- and antibody- testing. The roles of biosensors as powerful analytical tools are emphasized for the detection of viral RNAs, surface antigens, whole viral particles, antibodies and other potential biomarkers in human specimen. We critically review in depth newly developed biosensing methods especially for in-field and point-of-care detection of SARS-CoV-2. Additionally, this review describes possible future strategies for virus rapid detection. It helps researchers working on novel sensor technologies to tailor their technologies in a way to address the challenge for effective detection of COVID-19.
Assuntos
Betacoronavirus/isolamento & purificação , Técnicas Biossensoriais , Técnicas de Laboratório Clínico , Infecções por Coronavirus/diagnóstico , Pneumonia Viral/diagnóstico , Testes Imediatos , Animais , Técnicas Biossensoriais/economia , Técnicas Biossensoriais/instrumentação , Técnicas Biossensoriais/métodos , COVID-19 , Teste para COVID-19 , Técnicas de Laboratório Clínico/economia , Técnicas de Laboratório Clínico/instrumentação , Técnicas de Laboratório Clínico/métodos , Infecções por Coronavirus/economia , Desenho de Equipamento , Humanos , Pandemias , Testes Imediatos/economia , SARS-CoV-2 , Fatores de TempoRESUMO
Lung sounds acquired by stethoscopes are extensively used in diagnosing and differentiating respiratory diseases. Although an extensive know-how has been built to interpret these sounds and identify diseases associated with certain patterns, its effective use is limited to individual experience of practitioners. This user-dependency manifests itself as a factor impeding the digital transformation of this valuable diagnostic tool, which can improve patient outcomes by continuous long-term respiratory monitoring under real-life conditions. Particularly patients suffering from respiratory diseases with progressive nature, such as chronic obstructive pulmonary diseases, are expected to benefit from long-term monitoring. Recently, the COVID-19 pandemic has also shown the lack of respiratory monitoring systems which are ready to deploy in operational conditions while requiring minimal patient education. To address particularly the latter subject, in this article, we present a sound acquisition module which can be integrated into a dedicated garment; thus, minimizing the role of the patient for positioning the stethoscope and applying the appropriate pressure. We have implemented a diaphragm-less acousto-electric transducer by stacking a silicone rubber and a piezoelectric film to capture thoracic sounds with minimum attenuation. Furthermore, we benchmarked our device with an electronic stethoscope widely used in clinical practice to quantify its performance.
Assuntos
Betacoronavirus , Técnicas de Laboratório Clínico/instrumentação , Infecções por Coronavirus/diagnóstico , Infecções por Coronavirus/fisiopatologia , Monitorização Ambulatorial/instrumentação , Pneumonia Viral/diagnóstico , Pneumonia Viral/fisiopatologia , Sons Respiratórios/diagnóstico , Sons Respiratórios/fisiopatologia , Estetoscópios , Dispositivos Eletrônicos Vestíveis , Acústica , Auscultação/instrumentação , COVID-19 , Teste para COVID-19 , Impedância Elétrica , Desenho de Equipamento , Humanos , Pandemias , Tecnologia de Sensoriamento Remoto/instrumentação , SARS-CoV-2 , Processamento de Sinais Assistido por Computador , Transdutores , Tecnologia sem Fio/instrumentaçãoRESUMO
Background: Drug-resistant tuberculosis (TB) is an ongoing health threat, and the greatest challenge to adequate control of TB in many countries lies in the lack of proper laboratory drug-susceptibility test. The aim of this study was to evaluate the activity-based costs (ABC) of Kit SIRE Nitratase® (Kit SIRE) and compare its values with the conventional drug-susceptibility test. Methods: The ABC was calculated for three different approaches: Kit SIRE (clinical samples and cultures), proportion methods in Lowenstein Jensen (PM-LJ), and the Bactec™ MGIT™ 960 system based on Mycobacterial Research Laboratory's routine. Results: The ABC of Kit SIRE from cultures was US$ 148.54, while from clinical samples was US$ 136.12. In the case of conventional tests, the ABC of Bactec™ MGIT™ 960 was US$ 227.63 and of the PM-LJ was US$ 132.64. The Kit SIRE has a lower ABC when clinical samples are used instead of cultures. Compared to conventional tests, the ABC is similar to the PM-LJ and lower the Bactec™ MGIT™ 960. Conclusion: The Kit SIRE should be used as a screening method in clinical specimens and in culture for laboratories that do not have Bactec™ MGIT™ 960. Therefore, it can be incorporated into the routine of laboratories in countries with low resources and a high burden of TB and drug-resistant TB.
Assuntos
Antituberculosos/farmacologia , Técnicas de Laboratório Clínico/instrumentação , Mycobacterium tuberculosis/efeitos dos fármacos , Kit de Reagentes para Diagnóstico/economia , Brasil , Técnicas de Laboratório Clínico/economia , Recursos em Saúde/economia , Hospitais , Humanos , Testes de Sensibilidade Microbiana/economia , Centros de Atenção Terciária , Tuberculose Resistente a Múltiplos Medicamentos/microbiologiaAssuntos
Técnicas de Laboratório Clínico/normas , Infecções por Coronavirus/diagnóstico , Pneumonia Viral/diagnóstico , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Betacoronavirus/isolamento & purificação , COVID-19 , Técnicas de Laboratório Clínico/economia , Técnicas de Laboratório Clínico/instrumentação , Técnicas de Laboratório Clínico/estatística & dados numéricos , Equipamentos para Diagnóstico/economia , Equipamentos para Diagnóstico/normas , Humanos , Ciência de Laboratório Médico/economia , Ciência de Laboratório Médico/instrumentação , Ciência de Laboratório Médico/normas , Pandemias , Reação em Cadeia da Polimerase Via Transcriptase Reversa/economia , Reação em Cadeia da Polimerase Via Transcriptase Reversa/instrumentação , Reação em Cadeia da Polimerase Via Transcriptase Reversa/normas , SARS-CoV-2RESUMO
OBJECTIVES: To establish the optimal parameters for group testing of pooled specimens for the detection of SARS-CoV-2. METHODS: The most efficient pool size was determined to be five specimens using a web-based application. From this analysis, 25 experimental pools were created using 50 µL from one SARS-CoV-2 positive nasopharyngeal specimen mixed with 4 negative patient specimens (50 µL each) for a total volume of 250 µL. Viral RNA was subsequently extracted from each pool and tested using the CDC SARS-CoV-2 RT-PCR assay. Positive pools were consequently split into individual specimens and tested by extraction and PCR. This method was also tested on an unselected group of 60 nasopharyngeal specimens grouped into 12 pools. RESULTS: All 25 pools were positive with cycle threshold (Ct) values within 0 and 5.03 Ct of the original individual specimens. The analysis of 60 specimens determined that 2 pools were positive followed by identification of 2 individual specimens among the 60 tested. This testing was accomplished while using 22 extractions/PCR tests, a savings of 38 reactions. CONCLUSIONS: When the incidence rate of SARS-CoV-2 infection is 10% or less, group testing will result in the saving of reagents and personnel time with an overall increase in testing capability of at least 69%.
Assuntos
Técnicas de Laboratório Clínico/economia , Técnicas de Laboratório Clínico/métodos , Pessoal de Laboratório Médico/economia , Manejo de Espécimes/economia , Manejo de Espécimes/métodos , Betacoronavirus/genética , Betacoronavirus/isolamento & purificação , Teste para COVID-19 , Técnicas de Laboratório Clínico/instrumentação , Técnicas de Laboratório Clínico/normas , Infecções por Coronavirus/diagnóstico , Infecções por Coronavirus/economia , Humanos , RNA Viral/genética , RNA Viral/isolamento & purificação , Reação em Cadeia da Polimerase Via Transcriptase Reversa/economia , SARS-CoV-2 , Manejo de Espécimes/normasRESUMO
BACKGROUND: Drones or unmanned aerial vehicles are autonomous or remotely controlled multipurpose aerial vehicles driven by aerodynamic forces and capable of carrying a payload. Whereas initially used exclusively for military purposes, the use of drones has gradually spread into other areas. Given their great flexibility and favourable costs, the use of drones has also been piloted in various healthcare settings. OBJECTIVES: We briefly summarize current knowledge regarding the use of drones in healthcare, focusing on infectious diseases and/or microbiology when applicable. SOURCES: Information was sought through PubMed and extracted from peer-reviewed literature published between January 2010 and August 2019 and from reliable online news sources. The search terms 'drones', 'unmanned aerial vehicles', 'microbiology' and 'medicine' were used. CONTENT: Peer-reviewed literature on the use of drones in healthcare has steadily increased in recent years. Drones have been successfully evaluated in various pilot programmes and are already implemented in some settings for transporting samples and delivering blood, vaccines, medicines, organs, life-saving medical supplies and equipment. In addition, a promising proof-of-concept 'lab-on-a-drone' was recently presented, as well as several pilot studies showing the benefits of drone use in surveillance and epidemiology of infectious diseases. IMPLICATIONS: The potential for drone use in clinical microbiology, infectious diseases and epidemiology is vast. Drones may help to increase access to healthcare for individuals that might otherwise not benefit from appropriate care due to remoteness and lack of infrastructure or funds. However, factors such as national airspace legislation and legal medical issues, differences in topography and climates, cost-effectiveness, and community attitudes and acceptance in different cultures and societies currently impede the widespread use of drones. Significant cost savings compared with ground transportation, speed and convenience of delivery, and the booming drone sector will probably drive drone implementation in various areas of medicine in the next 5 years.
Assuntos
Técnicas de Laboratório Clínico/instrumentação , Atenção à Saúde/métodos , Medicina Militar/instrumentação , Doenças Transmissíveis/diagnóstico , Custos e Análise de Custo , Atenção à Saúde/normas , Serviços Médicos de Emergência/métodos , Humanos , Técnicas Microbiológicas/instrumentação , Medicina Militar/métodosRESUMO
La tinta del documento está bastante opaca. DRACES [Departamento de Regulación, Acreditación y Control de Establecimientos de Salud] Este documento tiene como objeto: "la regulación, autorización y control de los laboratorios de diagnóstico clínico y/o de vigilancia epidemiológica, en concordancia con el Reglamento para la Regulación, Autorización, Acreditación y Control de Establecimientos de Atención para la Salud, Acuerdo Gubernativo 376-2007." Es de carácter obligatorio, por lo que se aplica tanto al sector público, privado, social o subsector de la seguridad social, en todo el territorio nacional. Contiene además, las definiciones de los conceptos relacionados al tema principal, además de la infraestructura que deberá tener cada clínica, incluidos el equipo y recurso humano y técnico. En el capítulo II, incluye una clasificación del nivel de laboratorios, describiendo sus características, servicios, horarios, materiales técnicos y equipos.
Assuntos
Humanos , Masculino , Feminino , Técnicas de Laboratório Clínico/classificação , Serviços de Laboratório Clínico/organização & administração , Laboratórios/legislação & jurisprudência , Pessoal de Laboratório Médico/normas , Pessoal de Laboratório Médico/organização & administração , Contenção de Riscos Biológicos/normas , Técnicas de Laboratório Clínico/instrumentação , Serviços de Laboratório Clínico/normas , Guatemala , Laboratórios/organização & administraçãoRESUMO
BACKGROUND: Verification of the performance of analytical platforms is indicated prior to adoption of new Technology for patient sample analysis. Acceptance criteria for the performance of coagulation analytical platforms are not always readily available and is complicated by the multiple assays and test principles in this section of the clinical laboratory. Coagulation samples are also prone to pre-analytical, post-sample collection variables potentially interfering with accuracy analysis. METHODS: This verification study assessed the accuracy of the automated STAGO STA-R Max® coagulation analyzers by means of a comparison study of results obtained on the previously validated STAGO STA-R Evolution® analyzer for 22 coagulation parameters on 40 individual patient samples for each parameter. Within- and between- run reproducibility on commercial control material, carry-over from abnormal to normal samples and the interference of bilirubin, hemoglobin and lipids on the chromogenic analytical channel were also assessed. Ongoing evaluation of the analyzer performance was assessed by External Quality Assurance (EQA) scheme participation. RESULTS: The reproducibility (precision) on 2 levels (Normal and Pathological) commercial control material was acceptable with co-efficient of variance (CV) results below the manufacturer target % CVs. The correlation study demonstrated accuracy of results obtained on the analyzers for all parameters except for D-dimers and coagulation Factor VII. Subsequent EQA performance for these two parameters were however satisfactory. Interference from bilirubin, hemoglobin and lipids did occur in the chromogenic channel. No clinically significant carry over from abnormal to normal samples were observed. CONCLUSIONS: The performance of the STAGO STA-R Max® analyzer is acceptable across the full coagulation test repertoire with the exception of the von Willebrand activity assay. Participation in EQA scheme assessments will be an integral part of ongoing monitoring of the performance of this automated analyzer.
Assuntos
Automação Laboratorial/instrumentação , Testes de Coagulação Sanguínea/instrumentação , Coagulação Sanguínea , Técnicas de Laboratório Clínico/instrumentação , Garantia da Qualidade dos Cuidados de Saúde , Automação Laboratorial/métodos , Automação Laboratorial/normas , Testes de Coagulação Sanguínea/métodos , Testes de Coagulação Sanguínea/normas , Serviços de Laboratório Clínico/normas , Técnicas de Laboratório Clínico/métodos , Técnicas de Laboratório Clínico/normas , Humanos , Laboratórios/normas , Reprodutibilidade dos Testes , África do SulRESUMO
The European parliament finally approved the new European in vitro diagnostic regulation (IVDR) on 5 April 2017. This new regulation is shaking up the industry as it has a wider scope than its predecessor, meaning manufacturers of in vitro diagnostic medical devices must revise their compliance strategies exhaustively. In order to help manufacturers begin the process of compliance, this article highlights the principal changes in the regulation, providing a starting point for industry players. Furthermore, the article draws attention to other obstacles to conformity, in particular the shortage of notified bodies, the organisations designated by member states to carry out compliance evaluations. In addition to the commercial stakes for businesses, it is essential to bear in mind the ultimate objective of this overhaul of the regulatory framework, namely, to improve patient safety.
Assuntos
Comércio/legislação & jurisprudência , União Europeia , Legislação de Dispositivos Médicos , Kit de Reagentes para Diagnóstico , Técnicas de Laboratório Clínico/instrumentação , Técnicas de Laboratório Clínico/normas , Segurança de Equipamentos , Europa (Continente) , União Europeia/economia , Humanos , Legislação de Dispositivos Médicos/economia , Segurança do Paciente , Kit de Reagentes para Diagnóstico/classificação , Kit de Reagentes para Diagnóstico/economia , Kit de Reagentes para Diagnóstico/normasAssuntos
Serviços de Laboratório Clínico/economia , Técnicas de Laboratório Clínico/instrumentação , Sistemas Automatizados de Assistência Junto ao Leito/economia , Técnicas de Laboratório Clínico/economia , Humanos , Técnicas de Amplificação de Ácido Nucleico , Infecções Respiratórias/diagnóstico , Infecções Respiratórias/economia , Infecções Respiratórias/virologiaRESUMO
Las actividades del laboratorio de análisis clínicos están fuertemente identificadas con el ritmo del cambio tecnológico. En los últimos treinta años se vive un cambio de época que afecta la cultura y la experiencia humana en todos sus aspectos. Este cambio modifico el modelo de producción. En el laboratorio ha incorporado tecnología que combina la química, la robótica, la óptica y la informática, y se ha impuesto como premisa externa de cambio un modelo de gestión global que afecta la forma de trabajo, la gestión y el rol de los profesionales (bioquímicos y técnicos). El hospital Garrahan inscribe su historia dentro de este periodo histórico y el proceso de cambio ha generado y genera incertidumbre, resistencia y adecuaciones al nuevo paradigma impuesto. Nos fijamos como objetivo analizar el impacto de este cambio sobre la gestión de procesos del laboratorio de nuestro hospital. Comprobamos que la demanda del laboratorio se incrementó al ritmo del crecimiento de consultas y egresos de pacientes, y de como este aumento demando adecuaciones de gestión, modificaciones arquitectónicas, incorporación de tecnologías (algunas emergentes), aumento en la trazabilidad de muestras y resultados, y mejoras en la seguridad del paciente en todos sus aspectos. Describimos el nuevo paradigma, sus ventajas, las adecuaciones hechas y los tiempos en que se fueron realizados. Concluimos sugiriendo un rol para los profesionales del laboratorio en función del paradigma en curso
Activities at the laboratory of clinical analysis are closely related to the pace of technological change. Over the past 30 years there has been a change of times affecting human culture and experience in all its aspects. This change has modified the model of production. The laboratory has incorporated technology combining chemistry, robotics, and optics, as well as information technology, and the premise of a global management model has been imposed affecting the way of working, administration, and the role of professionals (biochemists and technicians). Garrahan hospital has written its own history in this historical period and process of change has produced uncertainty, resistance as well as adaptation to this new paradigm. Our aim has been to analyze the impact of this change on the management of processes of the laboratory of our hospital. We have observed that the demand of the laboratory has increased at the same pace as the increase of patient visits and discharges. This increase has required modifications in the management and facilities, incorporation of new technologies (some of them state of the art), improved traceability of the samples and results, and improvements in patient safety in all aspects. Here we describe the new paradigm, its advantages, adaptations made, and improved times introduced. In our conclusions, we consider the new role for laboratory professionals in this paradigm.
Assuntos
Serviços de Laboratório Clínico/organização & administração , Serviços de Laboratório Clínico/estatística & dados numéricos , Técnicas de Laboratório Clínico/instrumentação , Equipamentos de Laboratório , Desenvolvimento Tecnológico , Automação , Segurança do Paciente , Gestão da Qualidade TotalRESUMO
The recent advances in the field of flow cytometry have resulted in instrumentation with increased capacity which is actually more user-friendly. Thus, the technology has become more valuable to research scientists, the pharmaceutical industry and clinical laboratories. The use of flow cytometry in regulated labs has been hampered by the challenges associated method validation and the lack of official guidance documents on the topic. Thus key stakeholders have published recommendation papers with the hope that these will be incorporated as official guidance documents. This review will focus on the achievements of the stakeholders and a high-level overview their recommendations.
Assuntos
Citometria de Fluxo/instrumentação , Citometria de Fluxo/métodos , Guias como Assunto , Pesquisa Biomédica/instrumentação , Pesquisa Biomédica/métodos , Técnicas de Laboratório Clínico/instrumentação , Técnicas de Laboratório Clínico/métodos , Indústria Farmacêutica/instrumentação , Indústria Farmacêutica/métodos , Humanos , Reprodutibilidade dos TestesRESUMO
The aim of the present study was to provide quantitative data of oral function in healthy subjects (HSs), validity of measurements and estimation of measurement bias, as well as quantify oral impairment in persons with scleroderma (SSc). 151 HSs and 12 subjects with SSc were recruited and assessed using instrumented tools, measuring maximal mouth opening; lip strength; and tongue strength, protrusion, retraction, and endurance. Twenty HSs were also retested 3-5 weeks later in order to assess the test-retest reliability of the measurements. Intraclass correlation coefficients proved to be satisfactory (>0.8) for both inter-rater and test-retest reliabilities of all measurements except for tongue retraction. In the HS group, maximal mouth opening and tongue and lips strength values were larger (P < 0.05) for males than females, while no significant differences were found for other variables. Older subjects had statistically significantly lower tongue retraction values and tongue endurance values than younger subjects. The SSc group showed a statistically significant decrease (P < 0.05) in almost all the measurements. Assessment procedures proved to be valid and reliable. Gender and height were predictors of mouth opening, lip and tongue strength, while age correlates with tongue retraction and endurance. Measurements highlighted the strong impact of SSc on oral functions and in particular on tongue protrusion, tongue strength, and endurance.
Assuntos
Técnicas de Laboratório Clínico/instrumentação , Boca/fisiologia , Força Muscular , Escleroderma Sistêmico/fisiopatologia , Adulto , Idoso , Idoso de 80 Anos ou mais , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Resistência Física , Postura , Reprodutibilidade dos Testes , Adulto JovemRESUMO
The reality of laboratory diagnostics as a whole, and hemostasis testing in particular, is evolving under new paradigms of efficiency. The driving forces of health care and laboratory diagnostics in the third millennium are mainly represented by macro- and microeconomics. In a world with limited resources, shattered by an unprecedented economic crisis, laboratory diagnostics is undergoing a substantial reorganization, with emergence of new models under the imperative of terms, such as bedside testing, consolidation, and networking. The paradigms under which these changes are being developed include a variety of environment, preanalytical, technological, professional, and health-care aspects. The maintenance of continued quality is indeed the major challenge to be faced in the foreseeable future. In fact, some challenges prepotently emerge during a consolidation process, which basically involve delayed testing, centrifugation, transportation, and stability of the specimens, as well as the potential mismatch of sample matrix. This article is aimed to provide an overview of the current economic scenario of laboratory diagnostics and discuss the changing face of hemostasis testing in modern laboratories, providing a synthetic overview about potential drawbacks of actualized solutions.
Assuntos
Automação Laboratorial , Testes de Coagulação Sanguínea/instrumentação , Testes de Coagulação Sanguínea/métodos , Técnicas de Laboratório Clínico/métodos , Hemostasia , Austrália , Transtornos da Coagulação Sanguínea , Testes de Coagulação Sanguínea/economia , Testes de Coagulação Sanguínea/tendências , Técnicas de Laboratório Clínico/economia , Técnicas de Laboratório Clínico/instrumentação , Técnicas de Laboratório Clínico/tendências , Geografia , Política de Saúde , Humanos , Reprodutibilidade dos Testes , Estados UnidosRESUMO
The aim of this chapter is to review and examine different methods in order to display correct and efficient statistical techniques based on complete/incomplete data subject to different sorts of measurement error (ME) problems. Instrument inaccuracies, biological variations, and/or errors in questionnaire-based self-report data can lead to significant MEs in various clinical experiments. Ignoring MEs can cause bias or inconsistency of statistical inferences. The biostatistical literature well addresses two categories of MEs: errors related to additive models and errors caused by the limit of detection (LOD). Several statistical approaches have been developed to analyze data affected by MEs, including the parametric/nonparametric likelihood methodologies, Bayesian methods, the single and multiple imputation techniques, and the repeated measurement design of experiment. We present a novel hybrid pooled-unpooled design as one of the strategies to provide correct statistical inferences when data is subject to MEs. This hybrid design and the classical techniques are compared to show the advantages and disadvantages of the considered methods.
Assuntos
Biomarcadores/análise , Técnicas de Laboratório Clínico/instrumentação , Técnicas de Laboratório Clínico/estatística & dados numéricos , Teorema de Bayes , Humanos , Funções Verossimilhança , Limite de Detecção , Método de Monte Carlo , Reprodutibilidade dos Testes , Estatística como AssuntoRESUMO
OBJECTIVE: The self-monitoring of blood glucose plays a critical role in management of diabetes mellitus. Although laboratory comparisons of glucose meter accuracy are often acceptable, clinical comparisons show frequent inaccuracies. In this paper, we evaluate the accuracy of self-monitoring blood glucose meters using glucose meter and serum comparisons from a large Canadian laboratory. METHODS: This study was performed using secondary data obtained from the Laboratory Information System of Calgary Services, the sole provider of laboratory testing to Calgary and surrounding areas. We examined anonymous quality assurance data for glucose meter comparisons performed on home glucose meters between January 1, 2010, and April 30, 2013. RESULTS: A total of 39 542 comparisons were recorded on 18 540 different subjects. Overall, 6.7% of differences were greater than the current International Standards Organization standard of 15%, and 3.7% exceeded the Canadian guideline of 20%. CONCLUSIONS: Glucose meter checks were infrequently performed (on average, once per 1.6 years). A significant subset of meter results was inaccurate.
Assuntos
Automonitorização da Glicemia/instrumentação , Técnicas de Laboratório Clínico/instrumentação , Diabetes Mellitus/sangue , Garantia da Qualidade dos Cuidados de Saúde/normas , Adulto , Alberta/epidemiologia , Automonitorização da Glicemia/normas , Canadá/epidemiologia , Técnicas de Laboratório Clínico/normas , Análise Custo-Benefício , Diabetes Mellitus/epidemiologia , Feminino , Educação em Saúde , Conhecimentos, Atitudes e Prática em Saúde , Humanos , Masculino , Educação de Pacientes como Assunto , Vigilância da População , Reprodutibilidade dos TestesRESUMO
Assessment of oxidative stress is an important but technically challenging procedure in medical and biological research. The reactive oxygen metabolites (d-ROMs) test is a simple assay marketed for analyzing the total amount of hydroperoxides in serum via the Fenton's reaction. Earlier reports have raised a suspicion that a part of the signal detected in the assay comes from sources other than metabolites generated by oxidative stress. The aim of this study was to identify which serum components interfere with the d-ROMs signal. By application of sodium azide, ethylenediaminetetraacetic acid, sodium dodecylsulphate, varying temperature, and spiking endogenous substances we demonstrate that in the case of mammalian sera the assay determines ceruloplasmin (CP) activity with potential interferences from hydroperoxides, iron level, thiols, and albumin. In sera of avian species hydroperoxides contribute more to the test outcome, but the CP part is insensitive to inhibition by azide. In conclusion, this assay has deficiencies in terms of detecting realistic concentrations of hydroperoxides, is mostly measuring CP and is also interfered with other serum components, making it very difficult to interpret in most biological systems.
Assuntos
Técnicas de Laboratório Clínico/instrumentação , Estresse Oxidativo/fisiologia , Espécies Reativas de Oxigênio/metabolismo , Ceruloplasmina/análise , Ceruloplasmina/metabolismo , Humanos , Reprodutibilidade dos Testes , EspectrofotometriaRESUMO
BACKGROUND: To assess glucose meter performance in a diabetes antenatal clinic, focussing on clinical and pre-analytical factors that might impact on the quantification of meter accuracy and precision. METHODS: The Freestyle Lite and the Performa glucose meters were assessed by trained researchers. Finger stick glucose was measured and compared with plasma venous glucose, obtained from a concomitantly collected antecubital fossa sample. Venous plasma was separated on-site then sent to the laboratory for measurement of glucose using the hexokinase method (comparative method). Additional data collected included: (i) timing of and also (ii) quantity of last carbohydrate intake; (iii) time periods between collection, preparation and analysis of the venous sample; (iv) the haemolysis index of the plasma sample and (v) haematocrit. RESULTS: There were 104 participants. Both meters fulfilled ISO 15197 standards, with 99% and 97% of Freestyle Lite and Performa results, respectively, falling within acceptable limits for this standard. Both meters showed minor proportional bias, reading low at higher glucose values. Consensus error grid analysis showed 100% of results from the Freestyle Lite and 99% from the Performa falling within Zone A, thus the observed differences in measured capillary and venous plasma glucose were sufficiently minor that they would have little effect on clinical action. No association was observed between [capillary-plasma] glucose difference and the five variables outlined above. CONCLUSIONS: The two glucose meters tested showed a reassuringly acceptable level of performance, when assessed by a research team in the setting of a diabetes antenatal clinic.